Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes

被引:0
作者
Inger Johansson [1 ]
Yuchen Lu [1 ]
Yitian Zhou [1 ]
Kristi Krebs [2 ]
Martina Akcan [3 ]
Lili Milani [1 ]
Magnus Ingelman-Sundberg [3 ]
机构
[1] Karolinska Institutet,Department of Physiology and Pharmacology
[2] Karolinska Institutet and Karolinska University Hospital,Center for Molecular Medicine
[3] University of Tartu,Estonian Genome Centre, Institute of Genomics
关键词
Pharmacogenomics; Clopidogrel; Omeprazole; Antidepressants; Antipsychotics;
D O I
10.1186/s40246-025-00765-2
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Methodology for clinical genotyping of CYP2D6 and CYP2C19
    Henriques, Beatriz Carvalho
    Buchner, Avery
    Hu, Xiuying
    Wang, Yabing
    Yavorskyy, Vasyl
    Wallace, Keanna
    Dong, Rachael
    Martens, Kristina
    Carr, Michael S.
    Asl, Bahareh Behroozi
    Hague, Joshua
    Sivapalan, Sudhakar
    Maier, Wolfgang
    Dernovsek, Mojca Z.
    Henigsberg, Neven
    Hauser, Joanna
    Souery, Daniel
    Cattaneo, Annamaria
    Mors, Ole
    Rietschel, Marcella
    Pfeffer, Gerald
    Hume, Stacey
    Aitchison, Katherine J.
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [2] CYP2C19 and CYP2D6 genotypes in Pacific peoples
    Helsby, Nuala A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (05) : 1303 - 1307
  • [3] Pharmacogenetic Prediction of Individual Variability in Drug Response Based on CYP2D6, CYP2C9 and CYP2C19 Genetic Polymorphisms
    Chaudhry, Shafqat Rasul
    Muhammad, Sajjad
    Eidens, Moritz
    Klemm, Marco
    Khan, Dilaware
    Efferth, Thomas
    Weisshaar, Maria-Paz
    CURRENT DRUG METABOLISM, 2014, 15 (07) : 711 - 718
  • [4] Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer
    Brown, Jacob T.
    Schneiderhan, Mark
    Eum, Seenae
    Bishop, Jeffrey R.
    PHARMACOGENOMICS, 2017, 18 (07) : 601 - 605
  • [5] Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants
    Samadi, Mitra
    Beigi, Laleh
    Yadegari, Fatemeh
    Ansari, Alireza Madjid
    Majidzadeh-A, Keivan
    Eskordi, Maryam
    Farahmand, Leila
    GENETICA, 2022, 150 (05) : 289 - 297
  • [6] Pharmacogenomic testing for CYP2C19 and CYP2D6 in cyclic vomiting syndrome
    Patel, Milan
    Partovi, Omeed
    Karrento, Katja
    Garacchi, Zhuping
    Balasubramanian, Gokulakrishnan
    Venkatesan, Thangam
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36 (01)
  • [7] Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes
    Villagra, David
    Goethe, John
    Schwartz, Harold I.
    Szarek, Bonnie
    Kocherla, Mohan
    Gorowski, Krystyna
    Windemuth, Andreas
    Ruano, Gualberto
    BIOMARKERS IN MEDICINE, 2011, 5 (04) : 427 - 438
  • [8] Enantioselective Analysis of Citalopram and Escitalopram in Postmortem Blood Together with Genotyping for CYP2D6 and CYP2C19
    Carlsson, Bjorn
    Holmgren, Anita
    Ahlner, Johan
    Bengtsson, Finn
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2009, 33 (02) : 65 - 76
  • [9] Utility and adoption of CYP2D6 and CYP2C19 genotyping and its translation into psychiatric clinical practice
    Jurgens, G.
    Jacobsen, C. B.
    Rasmussen, H. B.
    Werge, T.
    Nordentoft, M.
    Andersen, S. E.
    ACTA PSYCHIATRICA SCANDINAVICA, 2012, 125 (03) : 228 - 237
  • [10] The Utility of CYP2D6 and CYP2C19 Variants to Guide Pharmacological Treatment in Complex Unipolar Major Depression: A Pilot Longitudinal Study
    Ramaraj, Reshma
    Al-Mahayri, Zeina N.
    Saleous, Reema
    Abdel Aziz, Karim
    Al-Mugaddam, Fadwa
    Al-Sabousi, Mouza
    Alhassani, Aysha
    Ahbabi, Noura Ali Al
    Stip, Emmanuel
    Patrinos, George P.
    Ali, Bassam R.
    Arnone, Danilo
    PSYCHIATRIC QUARTERLY, 2023, 94 (3) : 435 - 447